A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.
Elderly people with frailty, which affects up to one-quarter of over-50s, increased their endurance after a single dose of ...
A new study describes a technique that rejuvenates aging blood-forming stem cells and could help reduce the risk of age-related blood disorders.
Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells ...
News-Medical.Net on MSN
Alzheimer’s plaques decline after CAR-T immune cell treatment in preclinical study
By Hugo Francisco de Souza A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the possibility that engineered immune therapies could reshape future treatment ...
A genetics‑guided drug, compound 6, targets CARD9 to subtly calm gut inflammation in Crohn’s disease, pointing to safer, longer‑lasting, precision treatments.
Researchers hope to undertake clinical studies in multiple cancers, including ovarian cancer, glioblastoma, and others.
Insulin resistance plays a role in many diseases. The new research provides insights into why insulin resistance appears to be associated with neurodegenerative disorders. Corresponding author Kai ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results